Brisbane Transplant Infectious Diseases meeting 2024
The Brisbane Transplant Infectious Diseases meeting was a great success! We welcomed presenters from various disciplines focusing on transplant and infectious diseases care.
We look forward to hosting this meeting again in 2025, subscribe to CRE RESPOND to receive an invitation or keep an eye on our socials CRE RESPOND X or CRE RESPOND LinkedIn.
You can watch the presentations here.
We'd love to hear your feedback, including topic suggestions for the 2025 meeting, please take a minute to complete the brief survey here.
Program Overview
Session 1. Princess Alexandra Hospital
Chair: Dr Lana Sundac, Princess Alexandra Hospital, Queensland
Topics
Infections in liver transplant recipients: Dr Olivia Smibert, Austin Health (unfortunately, we do not have a recording of Dr Smibert's presentation)
BK virus research update: Dr Ryan Gately and Dr Laura De Souza, Princess Alexandra Hospital
Hepatitis C positive donor transplant guidelines Metro South Health: Dr Samantha Ng, Princess Alexandra Hospital
Cloaking antibodies in bacterial infection post-transplant: Dr Timothy Wells, Frazer Institute, UQ
Case presentation: Dr Drew Farquhar, Princess Alexandra Hospital
Transplant Coordinator session: Angela McInnes, Princess Alexandra Hospital
Session 2. The Prince Charles Hospital
Chair: Dr Alex Chaudhuri, The Prince Charles Hospital, Queensland
10:25am - 12noon
Topics
Cytomegalovirus immune assays in heart and lung transplantation: Dr Bradley Gardiner, Alfred Health
Non-tuberculous mycobacterial infections in heart and lung transplantation: Dr Andrew Burke, The Prince Charles Hospital
Azoles and therapeutic drug monitoring: Cassandra Vale, The Prince Charles Hospital
Experience of antifungal prophylaxis in heart transplantation: Dr Kanthi Vemuri and Dr Maryam Khorramshahi Bayat, The Prince Charles Hospital
Case presentation: Dr Angus Lane, The Prince Charles Hospital
Session 3. Royal Brisbane and Women's Hospital
Chair: Associate Professor Krispin Hajkowicz, Royal Brisbane and Women's Hospital
1pm - 2:35pm
Topics
Vaccination in Cellular Therapy Patients: Associate Professor Benjamin Teh, Peter MacCallum Cancer Centre
Cellular therapies for infectious diseases: Professor Rajiv Khanna, QIMR Berghofer Medical Research Institute
CAR-T cell therapy and infection: Dr Nilu Perera, Royal Brisbane and Women's Hospital
Metagenomic diagnosis of infectious diseases in haemopoietic stem cell transplant recipients: Associate Professor Krispin Hajkowicz, Royal Brisbane and Women's Hospital
Case presentation: Dr Jessica Pearce, Royal Brisbane and Women's Hospital
Session 4. Queensland Children's Hospital
Chair: Associate Professor Julia Clark, Queensland Children's Hospital
3pm - 4:45pm
Topics
Increased virologic risk donors and HIV: Dr Tina Marinelli, Royal Prince Alfred Hospital
Donor derived Candida infections: Dr Sophie Wen, Queensland Children's Hospital
Refractory resistant cytomegalovirus infection: Jocelyn Hume, Queensland Children's Hospital
Valganciclovir therapeutic drug monitoring: Nicolette Graham, Queensland Children's Hospital
Case presentation: Dr Rebecca Ward, Queensland Children's Hospital
Close
4:45pm - 5pm Dr Adam Stewart, UQ Centre for Clinical Research and Sunshine Coast University Hospital
Thank you to sponsors: 
About Brisbane Transplant Infectious Diseases Meeting
The organising committee were pleased to present the 2nd Brisbane Transplant Infectious Diseases meeting on Thursday 23 May 2024. This was an interdisciplinary and collaborative meeting focused on transplant and infectious diseases care.
Bringing together local clinicians, scientists, and other healthcare professionals working in the field of infectious diseases, immunology, and transplant medicine. The meeting gave individuals a stage to present their active research or clinical interests, as well as to form successful research and clinical relationships between healthcare specialty groups and basic science researchers.
By shining a light on the clinical challenges of transplant patients in Queensland related to infectious diseases, we hope to provide a platform for cutting-edge translational research and improved patient care.
The full-day seminar series was held at the Translational Research Institute, Woolloongabba, Queensland, Australia.